| 翻訳と辞書 |
Sequenom
Sequenom () is an American company based in California, that develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT and liquid biopsy for cancer testing. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21 PLUS, a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, RetnaGene AMD a genetic test for the risk of progression for age-related macular degeneration, Heredi-T Cystic Fibrosis Screening Test, and the SensiGene Fetal RHD Genotyping Test.
In June 2014 the company sold its biosciences unit to Agena Bioscience for up to $35.8 million.〔(【引用サイトリンク】title=Sequenom sells bioscience unit )〕
==Competition==
Companies also offering non-invasive prenatal genetic testing include Ariosa,〔(【引用サイトリンク】title=Ariosa Diagnostics )〕 Ravgen,〔(【引用サイトリンク】title=A Noninasive Test to Determine Paternity in Pregnancy )〕 Illumina (Verinata Health),〔(【引用サイトリンク】title=Verinata )〕 and Natera (The Panorama Prenatal Test),. Other companies and universities that are working towards developing non-invasive prenatal testing include Stanford University,.〔(【引用サイトリンク】title=Non-invasive prenatal test for Down's syndrome developed )〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Sequenom」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|